According to INmune Bio's latest financial reports and stock price the company's current Operating Margin is -26,333.60%. At the end of 2023 the company had an Operating Margin of -19,360.00%.
Year | Operating Margin | Change |
---|---|---|
2023 | -19,360.00% | 165.23% |
2022 | -7,299.20% | -56.46% |
2021 | -16,762.43% | -84.76% |
2020 | -109,990.91% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.